Source: Annual Congress 2013 –Drug-resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
I. Vasilyeva, A. Samoilova, E. Larionova, T. Smirnova, T. Bagdasaryan, L. Chernousouva (Moscow, Russian Federation). Efficacy of treatment of MDR/XDR TB patients based on rapid diagnostics of M. tuberculosis drug resistance by GenoType MTBDRplus and GenoType MTBDRsl (Hain Lifescience GmbH, Germany). Eur Respir J 2013; 42: Suppl. 57, 2811

Member's Comments

No comment yet.

Related content which might interest you: Genotype MTBDR (Hain) test in suspected MDR-TB patients Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 GenoType MTBDRsl performance on clinical samples with diverse genetic background}, Source: Eur Respir J 2012; 40: 690-698 Year: 2012 Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Is Xpert MTB/Rif Ultra superior to Xpert MTB/Rif for the diagnosis of tuberculosis in children in Uzbekistan Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis Source: Eur Respir J 2008; 32: 1165-1174 Year: 2008 Estimation of the role of the test GeneXpert MTB-RIF in the diagnosis of pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Detection of M. tuberculosis multi-drug resistance using GenoType® MTBDRplus Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 Role of the QuantiFERON®-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection Source: Eur Respir J 2012; 40: 1443-1449 Year: 2012 Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Source: Eur Respir J 2012; 39: 163-171 Year: 2012 Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Source: Eur Respir J 2011; 39: 163-171 Year: 2012 Rifampicin (Rif)-resistant tuberculosis (TB) on GeneXpert in Mumbai, India: How effective is the best derived empiric regimen? Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Gene-Xpert for rapid detection of MDR-TB in re-treatment cases;a comparison with standard culture and DST Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Rapid diagnosis of tuberculosis and rifampin resistance by GeneXpert MTB/RIF test Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018 Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil Source: ERJ Open Res, 5 (3) 00043-2019; 10.1183/23120541.00043-2019 Year: 2019